← Back
Data updated: Mar 10, 2026
CATALYST PHARMS
Neurology
CATALYST PHARMS is a specialty pharmaceutical company focused on Neurology. Key products include FYCOMPA.
2012
Since
3
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...